Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Diluted EPS of $6.79 per share for fiscal year 2025.
WEST PHARMACEUTICAL SERVICES INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $6.79 | +1.5% |
| 2024 | $6.69 | -15.1% |
| 2023 | $7.88 | +1.9% |
| 2022 | $7.73 | -10.8% |
| 2021 | $8.67 | +89.7% |
| 2020 | $4.57 | +42.4% |
| 2019 | $3.21 | +17.2% |
| 2018 | $2.74 | +37.7% |
| 2017 | $1.99 | +4.2% |
| 2016 | $1.91 | +46.9% |
| 2015 | $1.30 | -25.7% |
| 2014 | $1.75 | +11.5% |
| 2013 | $1.57 | +36.5% |
| 2012 | $1.15 | +6.5% |
| 2011 | $1.08 | -42.9% |
| 2010 | $1.89 | -10.8% |
| 2009 | $2.12 | -15.2% |
| 2008 | $2.50 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.92 | +3.8% | +5.5% |
| June 30, 2025 | $1.82 | +20.5% | +48.0% |
| March 31, 2025 | $1.23 | -20.6% | -33.5% |
| September 30, 2024 | $1.85 | -13.6% | +22.5% |
| June 30, 2024 | $1.51 | -26.7% | -2.6% |
| March 31, 2024 | $1.55 | -16.2% | -27.6% |
| September 30, 2023 | $2.14 | +34.6% | +3.9% |
| June 30, 2023 | $2.06 | -16.9% | +11.4% |
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +1.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2008–2025 period, WEST PHARMACEUTICAL SERVICES INC’s diluted eps has grown by 171.6% (from $2.50 per share to $6.79 per share).
- The most recent figure is from WEST PHARMACEUTICAL SERVICES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: